Earnings call transcript: Innoscripta falls 9% after Q2 2026 update

Innoscripta reported a 43% increase in first-half 2026 revenue, reaching EUR 63 million from EUR 44 million in the same period last year, while EBIT climbed 49% to EUR 36.4 million. However, the stock fell sharply by 9% after the company disclosed that a software migration delayed submissions and pushed some revenue into later quarters.

Despite this, management reaffirmed its full-year guidance for EUR 140 million in revenue and EUR 80 million in EBIT, stating that the business remains on track despite temporary timing effects. The stock is currently trading at a P/E ratio of 20.3 and has a market capitalization of $961 million, being considered undervalued by InvestingPro analysis.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.